SLNCF and SLN Related Headlines
Go Back- TreeFrog Therapeutics appoints Mark Rothera as new CEO
- TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth
SLNCF and SLN Related Press Releases
Go BackSLNCF and SLN Related SEC Filings
Go Back- Form S-8 Silence Therapeutics
- Form 10-K Silence Therapeutics For: Dec 31
- Form 8-K Silence Therapeutics For: Mar 05
- Form 4 Silence Therapeutics For: Aug 03 Filed by: Griffiths Richard Ian
- Form SCHEDULE 13G/A Silence Therapeutics Filed by: Lombard Odier Asset Management (USA) Corp
- Form 8-K Southland Holdings, Inc. For: Feb 04
- Form 8-K Southland Holdings, Inc. For: Jan 15
- Form 8-K Southland Holdings, Inc. For: Jan 16
- Form 4 Silence Therapeutics For: Jan 02 Filed by: HELLUMS RHONDA LYNETTE
- Form 4 Silence Therapeutics For: Jan 02 Filed by: Lemus David
- Form 4 Silence Therapeutics For: Jan 02 Filed by: MCINERNEY TIMOTHY
- Form 4 Silence Therapeutics For: Jan 02 Filed by: Romano Steven J.
- Form 4 Silence Therapeutics For: Jan 02 Filed by: Ede-Golightly James
- Form 8-K Southland Holdings, Inc. For: Dec 22
- Form 8-K Southland Holdings, Inc. For: Dec 17
- Form 4 Silence Therapeutics For: Dec 18 Filed by: Ross Iain
- Form 4 Silence Therapeutics For: Dec 22 Filed by: Ede-Golightly James
- Form 3 Silence Therapeutics For: Dec 14 Filed by: Ede-Golightly James
- Form 8-K/A Silence Therapeutics For: Dec 14
- Form 8-K Silence Therapeutics For: Dec 18
- Form 8-K Silence Therapeutics For: Dec 14
- Form 4 Southland Holdings, Inc. For: Jun 03 Filed by: Winn Walter Timothy
- Form SCHEDULE 13D/A Southland Holdings, Inc. Filed by: Winn Walter Timothy
- Form 10-Q Southland Holdings, Inc. For: Sep 30
- Form 8-K Southland Holdings, Inc. For: Nov 12
- Form 10-Q Silence Therapeutics For: Sep 30
- Form 8-K Silence Therapeutics For: Nov 06
- Form 8-K Silence Therapeutics For: Oct 23
- Form 4 Southland Holdings, Inc. For: Aug 15 Filed by: Bassano Keith
- Form 8-K Silence Therapeutics For: Aug 11
- Form 10-Q Southland Holdings, Inc. For: Jun 30
- Form 8-K Southland Holdings, Inc. For: Aug 12
- Form 10-Q Silence Therapeutics For: Jun 30
- Form 8-K Silence Therapeutics For: Aug 07
- Form 4 Silence Therapeutics For: Jul 31 Filed by: Griffiths Richard Ian
- Form 4 Silence Therapeutics For: Jul 29 Filed by: Griffiths Richard Ian
- Form 4 Silence Therapeutics For: Jul 21 Filed by: Griffiths Richard Ian
- Form 4 Silence Therapeutics For: Jul 11 Filed by: Griffiths Richard Ian
- Form 4 Silence Therapeutics For: Jul 07 Filed by: Griffiths Richard Ian
- Form 4 Silence Therapeutics For: Jun 26 Filed by: Griffiths Richard Ian
- Form 4 Southland Holdings, Inc. For: Jun 25 Filed by: Winn Walter Timothy
- Form 4 Southland Holdings, Inc. For: Jun 25 Filed by: Renda Rudolph V.
- Form 4 Southland Holdings, Inc. For: Jun 25 Filed by: Renda Frankie S.
- Form 8-K Silence Therapeutics For: Jun 26
- Form 4 Southland Holdings, Inc. For: Jun 25 Filed by: Parker Nathaniel Willis IV
- Form 3 Southland Holdings, Inc. For: May 19 Filed by: Parker Nathaniel Willis IV
- Form SCHEDULE 13D/A Silence Therapeutics Filed by: Griffiths Richard Ian
- Form 4 Silence Therapeutics For: Jun 22 Filed by: Griffiths Richard Ian
- Form 8-K Southland Holdings, Inc. For: Jun 13
- Form 4 Silence Therapeutics For: Jun 17 Filed by: Griffiths Richard Ian
- Form 4 Southland Holdings, Inc. For: Jun 13 Filed by: Ramirez Mario Enrique
- Form 4 Southland Holdings, Inc. For: Jun 13 Filed by: Monahan Gregory R
- Form 4 Southland Holdings, Inc. For: Jun 13 Filed by: Martins Izilda P
- Form 4 Southland Holdings, Inc. For: Jun 13 Filed by: Bassano Keith
- Form 4 Southland Holdings, Inc. For: Jun 13 Filed by: Renda Rudolph V.
- Form 4 Southland Holdings, Inc. For: Jun 13 Filed by: Winn Walter Timothy
- Form 4 Southland Holdings, Inc. For: Jun 13 Filed by: Renda Frankie S.
- Form 4 Silence Therapeutics For: Jun 12 Filed by: Griffiths Richard Ian

